November 26, 2012 | 6
Cell lines are standard tools in biomedical research, and yet when it comes to their genetic identity, they are remarkably unstable. That volatility comes with their defining trait—immortality. Over time, cells accumulate mutations that may ultimately change the structure of chromosomes and alter cellular functions.
A number of those genetic changes can be detected with cell line authentication, although despite the authority implied by its name, such testing is not yet performed routinely in many laboratories. In fact, for the better part of the 60 years since its inception, authentication has not featured prominently on scientists’ to-do lists. It was even actively dismissed for a time, because the manner in which attention had been called to scientists’ mistakes (in many cases committed unknowingly) was perceived as career-threatening.
By the 1960s, it was clear that authentication would be an effective way to catch obvious mix-ups and contamination between cell lines. But it would have been difficult to predict its usefulness for detecting the many diverse genetic variations that bear so critically on cell line identity over time, since those variations were unknown then. And even now, equipped with relatively advanced technologies and with an understanding that genetic variation can be both powerful in effect and subtle in form, they are still able to escape detection.
The elusiveness of variation is a fascinating aspect of cell biology, and its significance is emphasized particularly by the widespread use of immortalized cell lines in laboratory research and by the fact that genetic variation is now a cornerstone of biomedical science. Curiosity about variation in nature is not a new phenomenon, of course. Observations of plants, notably those recorded by Gregor Mendel and Dutch botanist Hugo De Vries in the 19th century, were critical to the realization that genetic variation is the basis for evolution by natural selection. Knowledge of induced mutation, or mutagenesis, introduced in the 1920s with the work of German geneticist Hermann Joseph Müller, piqued the interest of not only scientists but also writers and the general public, notably in the form of science fiction and comics, which are rife with mutant characters.
Still today it is difficult not to be amazed by genetic variation and mutagenesis. The depth of variation that exists in the human genome, for instance, is astonishing. In 2006 scientists reported that copy number variations, which include relatively large deletions, duplications, and insertions of genetic material that alter the structure of DNA, affect from 6 to 19 percent of any given chromosome in the human genome. Prior to that study, it had been estimated that just 0.1 percent of the human genome was affected by genetic variation, much of which had been attributed to single nucleotide polymorphisms, which alter individual building blocks of DNA (changing an A to a T, for example).
The sheer diversity of variation in humans is illustrated further by cancer. Scientists have identified nearly 225,000 unique variants for this disease alone. Presumably many of those represent acquired mutations, or changes that have occurred as a result of time or exposure to cellular stressors, such as certain chemicals.
Which brings us back to cell lines.
The longer cells are kept in culture, and the more stressors they are exposed to, the more mutations they acquire. Eventually, they gain the mutations they need to make them immortal, giving rise to a cell line. A cell line, then, is an established lineage of continuously dividing cells, one in which the cells have effectively surpassed the Hayflick limit, or the finite number of cell divisions that normally would bring about replicative senescence (a state in which cells are metabolically active but not capable of division).
In the human body, the time that cells require to overcome the Hayflick limit typically comes with aging, which leads to age-related diseases, such as cancer. Most human cell lines used in biomedical research have in fact been developed with cells isolated from patient tumors. Such cells have already acquired immortality-conferring mutations that facilitate cell-line establishment. Non-tumor-derived cells (“normal” cells), on the other hand, may require exposure to a cancer-causing virus or some form of genetic engineering to become immortal. Once immortalized, they are only several steps removed from becoming tumorigenic (capable of forming tumors when injected into animals).
Immortalization is key for enabling researchers to work with fairly homogenous populations of cells, making for more robust experiments and data. But with each passage, in which a subset of cells is transferred to a new plate or flask to encourage the growth of still more cells, other mutations begin to work their way into the genetic material, producing populations of cells with chromosomal abnormalities or other alterations. If passaged excessively, those populations may become dominant, ultimately changing the cell line’s genetic identity. For some cell lines, such as certain lineages of embryonic stem cells, such changes occur relatively rapidly, after a dozen or so passages, which can have implications for their clinical use.
An early advocate of implementing procedures to catch those identity crises before they resulted in the publication of inaccurate data was Walter Nelson-Rees, who specialized in the characterization of cells at the Naval Biosciences Laboratory in California. In the 1960s and ’70s, Nelson-Rees began validating cell lines using karyotype analysis (which had been used in the first authentication studies in the 1950s) combined with the identification of certain cell surface proteins and isoenzymes. He found that many cell lines were contaminated with genetic material from other cells lines and, perhaps most significantly, that some human cell lines had been overtaken by HeLa cells, the first established human line and the most widely distributed.
Many scientists were caught off guard by Nelson-Rees’s findings. His job essentially was to fact-check the genetic profiles of cancer cell lines. But it seems that many of the creators of the lines and other researchers who had used them became aware of their errors only after Nelson-Rees highlighted offending papers in a series of articles published in Science. His approach, while bringing attention to the problem, had a strong isolating effect on scientists, leading to the eventual condemnation of his work as unscientific.
Still, cell lines are not always what researchers think they are. While the most egregious errors—a human cell line that turns out to be hamster—seem to be relatively uncommon, at least 18 percent of cell lines continue to be misidentified. Methods of authentication have advanced significantly, owing mainly to the development of rapid and inexpensive tools for the analysis of very short, repetitive segments of DNA, known as short tandem repeats. So, it would seem that there is no reason not to have cells checked, although arguably authentication is not required for some types of cell research.
The responsibility of knowing when to verify cells, and actually following through on it, rests with scientists, since journals and funding agencies have been reluctant to require it. And maybe that is all right. The greatest motivating factor for authentication should not be fear of not being published or funded. Rather, it should be curiosity, the reason why scientists explore questions about the natural world in the first place.
Get 6 bi-monthly digital issues
+ 1yr of archive access for just $9.99